| CRYPTOCOCCOSIS | ||
A disease caused by organism Cryptococcus neoformans
|
||
| ENTRY
TO THE BODY Airborne basidiospores conidia enter the lungs. These spores are deposited in the alveoli. Habitat of these infective spores is unknown. Possibly grow on bird droppings.
|
||
|
|
CLINICAL FEATURES
|
|
![]() Image copyright (c) www.doctorfungus.org and used by permission |
Image kindly supplied from Bristol Biomedical Image Archive |
|
|
|
Most infected in the US are HIV infected. No reports of animal-to-human transmission. Human-to-human transmission is rare
|
|
|
|
RISK
GROUPS Immunocompromsed especially those with HIV Many individuals that are infected have weakened immune systems. Individuals undertaking steroid treatment, immunosuppressant drugs. Diabetes, and leukemia patients.
|
|
|
|
INCIDENCE
AND GLOBAL DISTRIBUTION 4th most common life threatening disease in aids patients. in USA, Common in Britain and Europe Incidence decreased since devlopment of antiretroviral therapies 90% of cases occur to AIDS and HIV sufferers. Commonest in men
|
|
|
|
DIAGNOSIS Spinal tap Examine fluid from spinal cord for fungus Culture of fungus will confirm diagnosis.
|
|
|
|
TREATMENT
AND PREVENTION Amphotericin B via IV for severe infections. Milder infections treated with oral medications, e.g. fluconazole. AIDS patients will have to undergo oral treatments for life due to high rate of relapse. No specific prevention measures as how the infection is contracted is not fully known |
|
Organisms causing Cryptococcosis Back to Systemic Mycoses Main Mycoses Menu |
||